Cargando…
Dual-tracer positron emission tomography/computed tomography as an imaging probe of de novo lipogenesis in preclinical models of hepatocellular carcinoma
BACKGROUND: De novo lipogenesis is upregulated in many cancers, and targeting it represents a metabolic approach to cancer treatment. However, the treatment response is unpredictable because lipogenic activity varies greatly among individual tumors, thereby necessitating the assessment of lipogenic...
Autores principales: | Tsao, Chin-Ho, Jhou, Rong-Hong, Ke, Chien-Chih, Chang, Chun-Wei, Chang, Chi-Wei, Yang, Bang-Hung, Huang, Wen-Sheng, Shih, Bing-Fu, Liu, Ren-Shyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551611/ https://www.ncbi.nlm.nih.gov/pubmed/36237546 http://dx.doi.org/10.3389/fmed.2022.1008200 |
Ejemplares similares
-
Tau Filaments and the Development of Positron Emission Tomography Tracers
por: Goedert, Michel, et al.
Publicado: (2018) -
Biodistribution and radiation dosimetry of multiple tracers on total-body positron emission tomography/computed tomography
por: Li, Lianghua, et al.
Publicado: (2023) -
First-in-class positron emission tomography tracer for the glucagon receptor
por: Velikyan, Irina, et al.
Publicado: (2019) -
Novel Positron Emission Tomography Tracers for Imaging Vascular Inflammation
por: Ćorović, Andrej, et al.
Publicado: (2020) -
Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose
por: Zhu, Jing, et al.
Publicado: (2022)